16:30 EST Contineum (CTNM) Therapeutics Inc trading resumes
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTNM:
- Contineum Phase 2 VISTA trial did not meet primary, secondary endpoints
- Contineum Therapeutics Inc trading halted, news pending
- Buy Rating for Contineum Therapeutics: Promising Advancements in Clinical Pipeline and Strategic Opportunities
- Contineum Therapeutics Reports Increased R&D Investment Amid Losses
- Contineum reports Q3 EPS (45c), consensus (46c)